4
Changes in Ownership
Protara Therapeutics, Inc. Filed Acc 0001209191-22-001715
Chief Financial Officer acquired 14,100 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Davis Blaine · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-03 | Grant or award : show line 1 in the form | +14,100 | 15,581 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-03 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +84,800 | 84,800 | D |
Loading xslF345X03/doc4.xml…